Skip to main content
. 2016 May 30;7(32):51069–51081. doi: 10.18632/oncotarget.9714

Table 4. Prognostic prediction by Kapplan–Meier survival analyses.

Factors 3–year OS (%) 5–year OS (%) MS (months) AIC C–index Log rank χ2 value P
N stage 898.7 0.687 151.1 < 0.001
N0 85.2 72.5 124.1 (7.5–176.0)
N1 76.1 63.4 113.0 (3.5–174.0)
N2 67.1 52.8 99.5 (1.4–172.4)
N3a 42.3 27.5 29.9 (0.9–160.0)
N3b 26.5 20.4 23.0 (0.3–172.7)
Nr stage 880.1 0.696 156.7 < 0.001
Nr0 85.2 72.5 124.1 (7.5–176.0)
Nr1 78.3 63.4 106.0 (1.4–160.0)
Nr2 58.4 46.9 54.9 (0.3–174.0)
Nr3 30.4 22.6 26.1 (0.9–172.7)
TNM stage 872.3 0.754 161.7 < 0.001
IA 92.6 82.5 134.2 (9.3–156.2)
IB 87.3 77.2 121.2 (1.4–172.4)
IIA 81.1 71.6 101.3 (0.3–174.0)
IIB 79.8 60.6 92.7 (4.0–176.0)
IIIA 66,2 55.4 82.6 (5.4–157.2)
IIIB 55.9 46.2 46.6 (0.9–150.3)
IIIC 33.1 22.2 25.4 (0.8–172.7)
TNrM stage 850.4 0.799 182.3 < 0.001
IA 92.6 82.5 134.2 (9.3–165.2)
IB 90.4 80.8 112.5 (6.5–176.0)
IIA 85.0 73.4 98.4 (1.4–160.9)
IIB 79.5 61.8 84.6 (0.3–173.1)
IIIA 64.3 57.0 65.4 (0.8–161.8)
IIIB 56.4 41.3 47.3 (0.9–175.6)
IIIC 30.2 22.4 24.0 (0.6–172.3)

OS: overall survival ; MS: median survival time; AIC: Akaike Information Criterion value; C–index: concordance index.